Published in J Clin Invest on January 01, 1966
Antihemophilic factor antigen. Localization in endothelial cells by immunofluorescent microscopy. J Clin Invest (1973) 4.57
Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest (1976) 3.04
Measurement of fibrinopeptide A in human blood. J Clin Invest (1974) 2.01
Plasma fibrinogen levels in normal and sick cows. Can J Comp Med (1970) 1.35
Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans. J Clin Invest (1991) 1.26
Platelet consumption by arterial prostheses: the effects of endothelialization and pharmacologic inhibition of platelet function. Ann Surg (1977) 1.24
Human prothrombin metabolism in normal man and in hypocoagulable subjects. J Clin Invest (1969) 1.09
Hyperacute rejection of renal homografts: with particular reference to coaglation changes, humoral antibodies, and formed blood elements. Transplant Proc (1971) 1.08
Incorporation of intravenously injected albumin, immunoglobulin G, and fibrinogen in guinea pig megakaryocyte granules. J Clin Invest (1989) 1.06
Direct measurement of the rates of synthesis of plasma proteins in control subjects and patients with gastrointestinal protein loss. J Clin Invest (1968) 1.04
The significance of variations in immunoreactive and clottable fibrinogen in health and following thrombosis. J Clin Pathol (1972) 0.94
Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention. J Clin Invest (1979) 0.94
Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism. J Clin Invest (1974) 0.92
Studies of the metabolism and distribution of fibrinogen in patients with hemophilia A. J Clin Invest (1967) 0.86
Reduced fibrinogen survival in diabetes mellitus. A reversible phenomenon. J Clin Invest (1979) 0.83
A rapidly produced 125I labelled autologous fibrinogen: in vitro properties and preliminary metabolic studies in man. J Clin Pathol (1976) 0.83
Plasminogen- 125 I responses in dogs to a single injection of urokinase and typhoid vaccine and to vascular injury. J Clin Invest (1972) 0.82
Physicochemical and biological properties of human and canine plasmins. J Clin Invest (1974) 0.82
Pharmacological enhancement of fibrinolytic activity and 125I-fibrinogen survival. J Clin Pathol (1970) 0.79
Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease. Respir Res (2014) 0.79
Behaviour of commercially prepared I-125 fibrinogen in metabolic studies. J Clin Pathol (1975) 0.77
Isotopic studies of therapeutic anticoagulation with a coagulating enzyme. J Clin Invest (1970) 0.75
Fibrin Formation, Structure and Properties. Subcell Biochem (2017) 0.75
Tracer experiments with I131 labeled human serum albumin: distribution and degradation studies. J Clin Invest (1953) 8.08
IN VIVO BEHAVIOR OF I-FIBRINOGEN. J Clin Invest (1963) 5.03
Studies on the metabolism of fibrinogen in two patients with congenital afibrinogenemia. Blood (1953) 2.51
Biosynthetic determination with radioactive sulfur of turn-over rates of various plasma proteins in normal and cirrhotic man. J Clin Invest (1955) 2.10
Observations on the distribution and biological half-life of human fibrinogen. Br J Haematol (1959) 1.88
The turnover of plasma fibrinogen. Acta Med Scand (1958) 1.52
FIBRINOGEN CATABOLISM IN HUMANS. Clin Sci (1964) 1.51
Studies of the metabolism and distribution of albumin with autologous I131-albumin in healthy men. J Lab Clin Med (1963) 1.32
Time-concentration curves and dilution spaces of T-1824 and I-1824 and I-131-labeled proteins in dogs. Am J Physiol (1961) 1.08
Mathematical models describing the distribution of I-131-albumin in man. J Lab Clin Med (1962) 1.00
Distribution and excretion of I-131-iodide in men on pharmacologic doses of iodides. J Lab Clin Med (1962) 0.99
TURNOVER AND DISTRIBUTION OF 131-IODINE-LABELLED HUMAN FIBRINOGEN. Thromb Diath Haemorrh (1964) 0.96
Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol (1999) 16.86
Structure of the cro repressor from bacteriophage lambda and its interaction with DNA. Nature (1981) 5.24
Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem (1988) 5.22
Emergence of a unique O3:K6 clone of Vibrio parahaemolyticus in Calcutta, India, and isolation of strains from the same clonal group from Southeast Asian travelers arriving in Japan. J Clin Microbiol (1997) 4.53
Spread of Vibrio cholerae O139 Bengal in India. J Infect Dis (1994) 3.91
Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome. Microb Pathog (1990) 3.88
DNA-binding proteins. Science (1983) 3.56
The molecular basis of DNA-protein recognition inferred from the structure of cro repressor. Nature (1982) 3.56
Immunological nonidentity of heat-labile enterotoxins from human and porcine enterotoxigenic Escherichia coli. Infect Immun (1981) 3.46
Modified Elek test for detection of heat-labile enterotoxin of enterotoxigenic Escherichia coli. J Clin Microbiol (1981) 3.37
Polymerase chain reaction for detection of the cholera enterotoxin operon of Vibrio cholerae. J Clin Microbiol (1991) 3.32
Production of cholera-like enterotoxin by a Vibrio cholerae non-O1 strain isolated from the environment. Infect Immun (1981) 3.21
Molecular epidemiologic evidence for association of thermostable direct hemolysin (TDH) and TDH-related hemolysin of Vibrio parahaemolyticus with gastroenteritis. Infect Immun (1990) 3.17
Identification of lethal toxin with the thermostable direct hemolysin produced by Vibrio parahaemolyticus, and some physicochemical properties of the purified toxin. Infect Immun (1976) 3.11
Development and evaluation of a multiplex PCR assay for rapid detection of toxigenic Vibrio cholerae O1 and O139. FEMS Immunol Med Microbiol (1998) 2.98
Detection of the thermostable direct hemolysin gene and related DNA sequences in Vibrio parahaemolyticus and other vibrio species by the DNA colony hybridization test. Infect Immun (1985) 2.90
Amino-acid sequence of a heat-stable enterotoxin produced by human enterotoxigenic Escherichia coli. Eur J Biochem (1982) 2.78
Non-O1 Vibrio cholerae hemolysin: purification, partial characterization, and immunological relatedness to El Tor hemolysin. Infect Immun (1984) 2.72
Clonal diversity among recently emerged strains of Vibrio parahaemolyticus O3:K6 associated with pandemic spread. J Clin Microbiol (1999) 2.66
Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology. J Clin Microbiol (1985) 2.66
Vibrio cholerae O139 Bengal in Bangkok. Lancet (1993) 2.64
Purification and some properties of a non-o1 Vibrio cholerae enterotoxin that is identical to cholera enterotoxin. Infect Immun (1983) 2.62
Lambda repressor recognizes the approximately 2-fold symmetric half-operator sequences asymmetrically. Proc Natl Acad Sci U S A (1989) 2.61
Isolation of a factor causing morphological changes of chinese hamster ovary cells from the culture filtrate of Vibrio parahaemolyticus. Infect Immun (1976) 2.56
Purification and partial characterization of heat-stable enterotoxin of enterotoxigenic Escherichia coli. Infect Immun (1979) 2.55
Demonstration of the cardiotoxicity of the thermostable direct hemolysin (lethal toxin) produced by Vibrio parahaemolyticus. Infect Immun (1976) 2.51
Sequential appearance of gamma/delta- and alpha/beta-bearing T cells in the peritoneal cavity during an i.p. infection with Listeria monocytogenes. Eur J Immunol (1990) 2.44
Distribution of the cytolethal distending toxin A gene (cdtA) among species of Shigella and Vibrio, and cloning and sequencing of the cdt gene from Shigella dysenteriae. Microb Pathog (1995) 2.27
Molecular evidence of clonal Vibrio parahaemolyticus pandemic strains. Emerg Infect Dis (2001) 2.24
Detection of the thermostable direct hemolysin gene (tdh) and the thermostable direct hemolysin-related hemolysin gene (trh) of Vibrio parahaemolyticus by polymerase chain reaction. Mol Cell Probes (1992) 2.22
Synthetic ColE1 plasmids carrying genes for cell division in Escherichia coli. Plasmid (1977) 2.22
Temporal shifts in traits of Vibrio cholerae strains isolated from hospitalized patients in Calcutta: a 3-year (1993 to 1995) analysis. J Clin Microbiol (1996) 2.21
Virulence genes in environmental strains of Vibrio cholerae. Appl Environ Microbiol (2000) 2.21
Amino acid sequence of Cro regulatory protein of bacteriophage lambda. Nature (1977) 2.18
Sequence variation in the thermostable direct hemolysin-related hemolysin (trh) gene of Vibrio parahaemolyticus. Appl Environ Microbiol (1992) 2.16
Immunological methods for detection of Kanagawa phenomenon of Vibrio parahaemolyticus. J Clin Microbiol (1980) 2.15
In vitro formation of hybrid toxins between subunits of Escherichia coli heat-labile enterotoxin and those of cholera enterotoxin. Infect Immun (1981) 2.12
Economic recession and health inequalities in Japan: analysis with a national sample, 1986-2001. J Epidemiol Community Health (2008) 2.11
Structure of the DNA-binding region of lac repressor inferred from its homology with cro repressor. Proc Natl Acad Sci U S A (1982) 2.09
A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc Natl Acad Sci U S A (1997) 2.07
Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis. Arthritis Rheum (1998) 2.01
DNA-dependent protein kinase (Ku protein-p350 complex) assembles on double-stranded DNA. Proc Natl Acad Sci U S A (1994) 2.01
Thermostable direct hemolysin of Vibrio parahaemolyticus. Pharmacol Ther (1982) 2.01
Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992-7 in Calcutta, India. Epidemiol Infect (2000) 1.96
Molecular analysis of non-O1, non-O139 Vibrio cholerae associated with an unusual upsurge in the incidence of cholera-like disease in Calcutta, India. J Clin Microbiol (1998) 1.94
Isolation of special antibodies which react only with homologous enterotoxins from Vibrio cholerae and Enterotoxigenic Escherichia coli. Infect Immun (1981) 1.94
Evidence that a non-O1 Vibrio cholerae produces enterotoxin that is similar but not identical to cholera enterotoxin. Infect Immun (1983) 1.93
Ribosomes from Escherichia coli merodiplods heterozygous for resistance to streptomycin and to spectinomycin. J Mol Biol (1968) 1.92
Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Microb Pathog (1987) 1.90
Existence of two distinct hemolysins in Vibrio parahaemolyticus. Infect Immun (1974) 1.90
Further evaluation of the Biken test (modified Elek test) for detection of enterotoxigenic Escherichia coli producing heat-labile enterotoxin and application of the test to sampling of heat-stable enterotoxin. J Clin Microbiol (1982) 1.89
Amino acid sequence of a heat-stable enterotoxin isolated from enterotoxigenic Escherichia coli strain 18D. FEBS Lett (1983) 1.85
Kinetic studies on Cro repressor-operator DNA interaction. J Mol Biol (1987) 1.85
Detection of various variant verotoxin genes in Escherichia coli by polymerase chain reaction. Microbiol Immunol (1993) 1.84
Structure and gene expression of the E. coli Mn-superoxide dismutase gene. Nucleic Acids Res (1986) 1.83
Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol Med Microbiol (1995) 1.83
Examination of diarrheagenicity of cytolethal distending toxin: suckling mouse response to the products of the cdtABC genes of Shigella dysenteriae. Infect Immun (1997) 1.80
A thermolabile direct hemolysin of Vibrio parahaemolyticus. Biken J (1969) 1.80
Virulence patterns of Vibrio cholerae non-O1 strains isolated from hospitalised patients with acute diarrhoea in Calcutta, India. J Med Microbiol (1993) 1.80
Cro regulatory protein specified by bacteriophage lambda. Structure, DNA-binding, and repression of RNA synthesis. J Biol Chem (1977) 1.78
Effect of heat (Arrhenius effect) on crude hemolysin of Vibrio parahaemolyticus. Infect Immun (1972) 1.78
Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2). Microb Pathog (1989) 1.78
Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis. Aliment Pharmacol Ther (2008) 1.77
The O139 serogroup of Vibrio cholerae comprises diverse clones of epidemic and nonepidemic strains derived from multiple V. cholerae O1 or non-O1 progenitors. J Infect Dis (2000) 1.76
Characterization of VPI pathogenicity island and CTXphi prophage in environmental strains of Vibrio cholerae. J Bacteriol (2001) 1.76
Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J Immunol (1999) 1.69
Antigenic difference between polar montrichous and peritrichous flagella of Vibrio parahaemolyticus. J Bacteriol (1974) 1.69
Emergence of a restricted bioserovar of Vibrio parahaemolyticus as the predominant cause of Vibrio-associated gastroenteritis on the West Coast of the United States and Mexico. J Clin Microbiol (1989) 1.68
Protein-DNA conformational changes in the crystal structure of a lambda Cro-operator complex. Proc Natl Acad Sci U S A (1990) 1.63
Hyperbaric oxygen reduces infarct volume in rats by increasing oxygen supply to the ischemic periphery. Crit Care Med (2000) 1.62
Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. J Exp Med (1997) 1.61
Development of a highly sensitive bead-ELISA to detect bacterial protein toxins. Microbiol Immunol (1988) 1.61
The evolution of genomic imprinting. Genetics (1996) 1.59
Essential structure for full enterotoxigenic activity of heat-stable enterotoxin produced by enterotoxigenic Escherichia coli. FEBS Lett (1985) 1.57
Cholera toxin production by the El Tor variant of Vibrio cholerae O1 compared to prototype El Tor and classical biotypes. J Clin Microbiol (2010) 1.56
Evidence for insertion sequence-mediated spread of the thermostable direct hemolysin gene among Vibrio species. J Bacteriol (1991) 1.55
Clonal dissemination of Vibrio parahaemolyticus displaying similar DNA fingerprint but belonging to two different serovars (O3:K6 and O4:K68) in Thailand and India. Epidemiol Infect (2000) 1.54
Purification and properties of a DNA-binding protein with characteristics expected for the Cro protein of bacteriophage lambda, a repressor essential for lytic growth. Proc Natl Acad Sci U S A (1976) 1.54
Survey of in vitro susceptibilities of Vibrio cholerae O1 and O139 to antimicrobial agents. Antimicrob Agents Chemother (1995) 1.54
Two sporadic cases of Liddle's syndrome caused by De novo ENaC mutations. Am J Kidney Dis (2001) 1.52
Synthetic ColE1 Plasmids carrying genes for penicillin-binding proteins in Escherichia coli. Plasmid (1981) 1.52
Case report: Occurrence of hepatocellular carcinoma 4.5 years after successful treatment with virus clearance for chronic hepatitis C. J Gastroenterol Hepatol (1999) 1.51
Traditional medicine in Turkey X. Folk medicine in Central Anatolia. J Ethnopharmacol (2001) 1.50
Spontaneous regression of hepatocellular carcinoma and review of literature. J Gastroenterol Hepatol (2000) 1.50
Resurgence of Vibrio cholerae O139 Bengal with altered antibiogram in Calcutta, India. Lancet (1996) 1.49
MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells. Br J Cancer (2010) 1.48
Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin. Microb Pathog (1987) 1.47
Argyrophilic proteins of the nucleolar organizer region in acute leukemias and its relation to the S-phase fraction of leukemic cells. Acta Haematol (1992) 1.46
A 1.2-A snapshot of the final step of bacterial cell wall biosynthesis. Proc Natl Acad Sci U S A (2001) 1.46
Demonstration of a temperature-dependent inactivating factor of the thermostable direct hemolysin in Vibrio parahaemolyticus. Infect Immun (1974) 1.46
Brunner's gland adenoma with a focus of p53-positive atypical glands. J Gastroenterol (2000) 1.46
Traditional medicine in Turkey. V. Folk medicine in the inner Taurus Mountains. J Ethnopharmacol (1995) 1.46
A functional comparison of animal anterior cruciate ligament models to the human anterior cruciate ligament. Ann Biomed Eng (1998) 1.45
Isolation and partial purification of thermolabile direct hemolysin of Vibrio parahaemolyticus. Biken J (1972) 1.45
Vibrio cholerae O139 in Calcutta, 1992-1998: incidence, antibiograms, and genotypes. Emerg Infect Dis (2000) 1.45
Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. J Urol (1997) 1.44
Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab (1978) 1.42
Cryptic appearance of a new clone of Vibrio cholerae serogroup 01 biotype El Tor in Calcutta, India. Microbiol Immunol (1997) 1.42
Cell vacuolation, a manifestation of the El tor hemolysin of Vibrio cholerae. Infect Immun (2000) 1.41
Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J Viral Hepat (2006) 1.39